AstraZeneca
AZN
#51
Rank
ยฃ211.42 B
Marketcap
ยฃ136.32
Share price
-1.52%
Change (1 day)
2.34%
Change (1 year)

P/S ratio for AstraZeneca (AZN)

P/S ratio as of November 2026 (TTM): 4.53

According to AstraZeneca's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.61. At the end of 2026 the company had a P/S ratio of 3.90.

P/S ratio history for AstraZeneca from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.90-20.41%
20254.9030.16%
20243.77-17.53%
20234.57-3.75%
20224.74-2.19%
20214.85-1.45%
20204.92-8.31%
20195.3725.56%
20184.2710.21%
20173.8829.36%
20163.00-14.32%
20153.503.59%
20143.3817.2%
20132.8837.53%
20122.1016.3%
20111.80-7.89%
20101.96-5.78%
20092.0810.47%
20081.88-10.96%
20072.11-31.88%
20063.10-4.92%
20053.2616.72%
20042.79-35.74%
20034.3527.15%
20023.42-1.11%
20013.46

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.75 49.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.24 15.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.55-43.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.86-14.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.6 221.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.95-57.05%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
3.60-20.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.25 15.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.51-44.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.21-51.21%๐Ÿ‡ฌ๐Ÿ‡ง UK